JP2023521330A5 - - Google Patents

Info

Publication number
JP2023521330A5
JP2023521330A5 JP2022561019A JP2022561019A JP2023521330A5 JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5 JP 2022561019 A JP2022561019 A JP 2022561019A JP 2022561019 A JP2022561019 A JP 2022561019A JP 2023521330 A5 JP2023521330 A5 JP 2023521330A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
receptor
flbr
tnfr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022561019A
Other languages
English (en)
Japanese (ja)
Other versions
JP7755597B2 (ja
JP2023521330A (ja
Filing date
Publication date
Priority claimed from GBGB2005331.0A external-priority patent/GB202005331D0/en
Priority claimed from GBGB2017358.9A external-priority patent/GB202017358D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/050866 external-priority patent/WO2021205176A2/en
Publication of JP2023521330A publication Critical patent/JP2023521330A/ja
Publication of JP2023521330A5 publication Critical patent/JP2023521330A5/ja
Priority to JP2025138496A priority Critical patent/JP2025170345A/ja
Application granted granted Critical
Publication of JP7755597B2 publication Critical patent/JP7755597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561019A 2020-04-09 2021-04-08 細胞 Active JP7755597B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138496A JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2005331.0 2020-04-09
GBGB2005331.0A GB202005331D0 (en) 2020-04-09 2020-04-09 Cell
GB2017358.9 2020-11-02
GBGB2017358.9A GB202017358D0 (en) 2020-11-02 2020-11-02 Cell
PCT/GB2021/050866 WO2021205176A2 (en) 2020-04-09 2021-04-08 Cell

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138496A Division JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Publications (3)

Publication Number Publication Date
JP2023521330A JP2023521330A (ja) 2023-05-24
JP2023521330A5 true JP2023521330A5 (cg-RX-API-DMAC7.html) 2024-02-09
JP7755597B2 JP7755597B2 (ja) 2025-10-16

Family

ID=75539696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022561019A Active JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Country Status (7)

Country Link
US (1) US20230113183A1 (cg-RX-API-DMAC7.html)
EP (1) EP4132963A2 (cg-RX-API-DMAC7.html)
JP (2) JP7755597B2 (cg-RX-API-DMAC7.html)
CN (1) CN115315439A (cg-RX-API-DMAC7.html)
AU (1) AU2021253759A1 (cg-RX-API-DMAC7.html)
CA (1) CA3174812A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021205176A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720949D0 (en) 2017-12-15 2018-01-31 Autolus Ltd Cell
JP2024541501A (ja) * 2021-11-25 2024-11-08 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ Cd95ポリペプチド
EP4476246A4 (en) * 2022-02-07 2026-05-13 Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute Recombinant proteins that stimulate an immune response in the presence of a naturally inhibitory ligand bond

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541845A (ja) 1999-04-16 2002-12-10 セルテック セラピューティックス リミテッド 合成膜貫通成分
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
US9931386B2 (en) * 2008-06-16 2018-04-03 Atsuo Ochi Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
SG11201707182WA (en) 2015-03-05 2017-10-30 Hutchinson Fred Cancer Res Immunomodulatory fusion proteins and uses thereof
JP7054924B2 (ja) * 2015-09-23 2022-04-15 サイトイミューン セラピューティクス, インコーポレイテッド 免疫療法のためのflt3指向car細胞
US11725210B2 (en) * 2017-03-17 2023-08-15 Fred Hutchinson Cancer Center Immunomodulatory fusion proteins and uses thereof
GB201716728D0 (en) * 2017-10-12 2017-11-29 Autolus Ltd Cell
GB201720949D0 (en) * 2017-12-15 2018-01-31 Autolus Ltd Cell
US20210363217A1 (en) * 2018-06-19 2021-11-25 Autolus Limited Cell
EP3856769A4 (en) * 2018-09-28 2022-08-17 Memorial Sloan Kettering Cancer Center IMMUNOREACTIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF

Similar Documents

Publication Publication Date Title
US12509499B2 (en) Therapeutic agents
KR20220027855A (ko) 원형 rna 조성물 및 방법
RU2017132293A (ru) Химерный белок
JP2022130485A5 (cg-RX-API-DMAC7.html)
JP6632073B2 (ja) キメラ抗原受容体
JP2023513502A (ja) コロナウイルスワクチン
RU2020109577A (ru) Клетка
RU2022102250A (ru) Клетка
JP2021502070A5 (cg-RX-API-DMAC7.html)
JP2025060882A5 (cg-RX-API-DMAC7.html)
JP2017537627A5 (cg-RX-API-DMAC7.html)
JP2015518479A5 (cg-RX-API-DMAC7.html)
JP2021522790A5 (cg-RX-API-DMAC7.html)
JP2022535005A5 (cg-RX-API-DMAC7.html)
CN106573989A (zh) 信号传导系统
JP2020513754A5 (cg-RX-API-DMAC7.html)
JP2019535262A5 (cg-RX-API-DMAC7.html)
JP2025170345A5 (cg-RX-API-DMAC7.html)
CA3206936A1 (en) Epigenetic gene regulation to treat neurological diseases and pain
JP2022542443A5 (cg-RX-API-DMAC7.html)
US20250302959A1 (en) Artificial immune receptors
TW202430551A (zh) 多發性骨髓瘤之bcma靶向car-t細胞療法
JP2023052688A (ja) 対合が改善されたt細胞受容体t細胞
JP2023548555A5 (cg-RX-API-DMAC7.html)
WO2025242073A1 (zh) 双靶点嵌合抗原受体、免疫效应细胞及应用